DOI: https://dx.doi.org/10.18203/2349-3933.ijam20221348
Published: 2022-05-24

Incidence of infections in patients with pemphigus vulgaris

Upma Narain, Tejas Kant, Arun Kant

Abstract


Background: Pemphigus is a rare, chronic autoimmune blistering disease of skin and mucous membranes. Autoimmune process and immunosuppressive therapy of pemphigus vulgaris would predispose the patients to infections. Therefore, the objective of this study was to isolate and identify the pathogens in admitted patients suffering from pemphigus vulgaris.

Methods: This was a retrospective observational study based on 68 diagnosed cases of pemphigus vulgaris (PV) admitted during January 1999 to April 2018 in SRN hospital, MLN medical college Prayagraj. Patients who had PV  and required admission owing to development of severe symptoms were included while patients with mild symptoms were excluded from the study. These admitted patients, along with routine and radiological examination, were also examined for microbiological examinations of sputum, throat swab, blood, body fluids, skin scrapings, stool and urine when necessary.

Results: Out of the 68 patients, 66.17% patients developed bacterial infections while 33.83% developed fungal infections. The prevalence of bacterial and fungal pathogens in urinary tract is 72.42% and 27.58%, pneumonitis is 29.42% and 70.58%, septicaemia is 81.82% and 18.18% and skin and soft tissue is 87.50% and 12.50% respectively. In meningitis and pulmonary tuberculosis no traces of fungi were recorded. Mortality was seen in 7.35% patients, which was due to bacterial meningitis, septicaemia and fungal pneumonitis.

Conclusions: The present study clearly states that the occurrence of the disease is uncommon but secondary infections are associated with worse prognosis. Therefore, the best regimen for each type of patients should base on the extent of disease and patient’s comorbidities.


Keywords


Infection, Pemphigus vulgaris, Autoimmune, Bacterial, Fungal

Full Text:

PDF

References


Sampaio SAP, Rivittu EA. (2007) Erupcoes Vesico-Bolhosas. In: Sampaio SAP, Rivitti EA, eds. Dermatologia. Sao Paulo: Artes Medicas Ltda; 2007: 301-30.

Sanchez-Perez J, Garcia-Diez A. Penfigo. Actas Dermosifiliogr. 2005;96(5):329-56.

Cunha PR, Barraviera SRCS. Autoimmune bullous dermatoses. An Bras Dermatol. 2009;84(2):111-24.

Buzina DS, Marinovi´c B. From pemphix to desmogleins. Clin Dermatol. 2011;29(4):355-9.

Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K, Hallaji Z, et al. Pemphigus: analysis of 1209 cases. Int J Dermatol. 2005;44(6):470-6.

Grando SA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity. 2012;45(1):7-35.

Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol. 1982;7(2):221-8.

Piamphongsant T, Ophaswongse S. Treatment of pemphigus. Int J Dermatol. 1991;30(2):139-46.

Narain U, Gupta A. Urinary tract infection in children with nephrotic syndrome. Pediatr Infect Dis J. 2018;37(2):144-6.

Narain U, Gupta A. Tuberculous meningitis in PD Patients. Ind J Periton Dialys. 2017;33:17-23.

Hertl M, Eming R. Autoimmune skin disorders, pemphigus. In: M. Hertl M, eds. Autoimmune Diseases of the Skin (Pathogenesis, Diagnosis, Management). Wien, Austria: Springer; 2011: 33-63.

Grammatikos AP, Tsokos GC. Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trend Mol Med. 2012;18(2):101-8.

Atkinson TP. Immune deficiency and autoimmunity. Curr Opin Rheumatol. 2012;24(5):515-21.

Huang YH, Kuo CF, Chen YH, Yang YW. Incidence, mortality, and causes of death of patients with pemphigus in Taiwan: a nationwide population-based study. J Invest Dermatol. 2012;132(1):92-7.

Rocha BNS, Oliveira CMM, Unger DAA. Estudo retrospectivo dos casos de penfigo (foliaceo e vulgar) diagnosticados no Servico de Dermatologia da Universidade Federal do Para/Fundacao Santa Casa de Misericordia do Para no periodo de julho de 1994 a julho de 2004. An Bras Dermatol. 2005;80:77-188.

Ramos W, Chacon GR, Galarza C, Gutierrez EL, Smith ME, Ortega-Loayza AG. Endemic pemphigus in the Peruvian Amazon: epidemiology and risk factors for the development of complications during treatment. An Bras Dermatol. 2012;87(6):838-45.

Wohl Y, Brenner S. Pemphigus in Israel-an epidemiologic analysis of cases in search of risk factors. Isr Med Assoc J. 2003;5(6):410-2.

Cheung HC. Pemphigus foliaceus: a clinical studyof 32 cases in Hong Kong. H K Dermatol Venereol Bull. 2004;12:126-32.

Esmaili N, Mortazavi H, Noormohammadpour P, Boreiri M, Soori T, Farahani IV, et al. Pemphigus vulgaris and infections: a retrospective study on 155 patients. Autoimm Dis. 2013.

Belgnaoui FZ, Senouci K, Chraibi H, Aoussar A, Mansouri F, Benzekri Z, et al. Predisposition to infection in patients with pemphigus. Retrospective study of 141 cases. Presse Med. 2007;36(11):1563-9.

Ljubojevic S, Lipozencic J, Brenner S, Budimcić D. Pemphigus vulgaris: a review of treatment over a 19-year period. J Eur Acad Dermatol Venereol. 2002;16(6):599-603.

Uzun S, Durdu M, Akman A, Gunasti S, Uslular C, Memisoglu HR, et al. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. Int J Dermatol. 2006;45(5):523-8.

Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris–incidence and mortality in the UK: population based COHORT study. BMJ. 2008;337(7662):180.